abstract |
Highly selective dual norepinephrine and serotonin aretoma inhibitors are provided. These compounds have a low collateral effect profile and are useful in compositions and products for use in the treatment of a variety of conditions including depression, fibromyalgia, anxiety, panic disorder, etc. |